Shelley B. Thunen

This profile gathers the share dealings of Shelley B. Thunen across 2 companies, led by RxSight, Inc. and AEON Biopharma, Inc. The record holds 13 filings, for trades running from 15 December 2023 to 17 June 2026.

Sales make up the whole of the open-market record (1 sale, €411k). Besides market trades, the filings include 2 share grants and 10 option exercises.

The latest filing, published on 22 June 2026, reports a share grant in AEON Biopharma, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.